2.00
0.11 (5.54%)
| 前收盘价格 | 1.90 |
| 收盘价格 | 1.88 |
| 成交量 | 2,266,467 |
| 平均成交量 (3个月) | 1,778,426 |
| 市值 | 195,237,312 |
| 价格/销量 (P/S) | 8.31 |
| 股市价格/股市净资产 (P/B) | 18.23 |
| 52周波幅 | |
| 利润日期 | 11 Mar 2026 |
| 营业利益率 (TTM) | -758.05% |
| 稀释每股收益 (EPS TTM) | -3.04 |
| 季度收入增长率 (YOY) | 310.40% |
| 总债务/股东权益 (D/E MRQ) | 49.88% |
| 流动比率 (MRQ) | 3.08 |
| 营业现金流 (OCF TTM) | -208.21 M |
| 杠杆自由现金流 (LFCF TTM) | -103.52 M |
| 资产报酬率 (ROA TTM) | -36.80% |
| 股东权益报酬率 (ROE TTM) | -140.82% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Editas Medicine, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.10 |
|
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.33% |
| 机构持股比例 | 57.56% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 8.00 (Jones Trading, 300.00%) | 购买 |
| 中 | 5.75 (187.50%) | |
| 低 | 3.50 (Chardan Capital, 75.00%) | 购买 |
| 平均值 | 5.75 (187.50%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 2.00 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Jones Trading | 10 Mar 2026 | 8.00 (300.00%) | 购买 | 2.00 |
| Chardan Capital | 09 Mar 2026 | 3.50 (75.00%) | 购买 | 2.00 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BURKLY LINDA | - | 2.04 | -749 | -1,528 |
| O'NEILL GILMORE NEIL | - | 2.04 | -5,394 | -11,004 |
| PARISON AMY | - | 2.04 | -474 | -967 |
| 累积净数量 | -6,617 | |||
| 累积净值 ($) | -13,499 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 2.04 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BURKLY LINDA | 职员 | 03 Mar 2026 | 卖 (-) | 749 | 2.04 | 1,528 |
| PARISON AMY | 职员 | 03 Mar 2026 | 卖 (-) | 474 | 2.04 | 967 |
| O'NEILL GILMORE NEIL | 职员 | 03 Mar 2026 | 卖 (-) | 5,394 | 2.04 | 11,004 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合